Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of age on remimazolam requirement for loss of consciousness in surgical adults and elderly patients
ChiCTR2300069582Phase 4Recruiting
- Sponsor
- Shidong Hospital
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam (2 arms), sponsored by Shidong Hospital. Primary endpoint: Amount of intravenous anesthetic used to induce disappearance of eyelash reflex. Started Apr 2023; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2300069582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069582.